Home
EN / FR

Celyad Oncology

Home / Investors / Shareholders Information

Shareholders Information

Shareholders Information

Equity Threshold (as of May 03, 2021)

Equity THRESHOLD_05032021

Voting Threshold (as of May 03, 2021)

Voting THRESHOLD_05032021

Total Number of Shares And Voting Rights

Total amount of share capital (EUR) (as of May 3rd, 2021) 52,211,200.33
Total number of shares with single voting rights (as of May 3rd, 2021) 12,637,131
Total number of shares with double voting rights (as of May 3rd, 2021) 2,368,025
Total number of shares (as of May 3rd, 2021) 15,005,156
Total number of voting rights (as of May 3rd, 2021) 17,373,181
Total number of attributed warrants (as of May 3rd, 2021) 1,802,756
Total number of shares with voting rights that could be created following the exercise of the attributed warrants (as of May 3rd, 2021) 1,802,756
Total number of diluted shares (outstanding shares + warrants) (as of May 3rd, 2021) 16,807,912
Total number of diluted shares with voting rights (as of May 3rd, 2021) 19.175.937

Transparency Declarations

05 May 2021 Tolefi SA
28 Sep 2018 Victory Capital Management Inc.
01 Jun 2018 Tolefi SA
17 Feb 2017 Tolefi SA
03 Aug 2016 Medisun International Ltd and National Fund Ltd
29 Jun 2015 PMV-TINA
29 Jun 2015 SRIW SA
05 Mar 2015 Tolefi SA
20 Aug 2014 Tolefi SA
12 Jul 2013 Tolefi SA, PMV NV, SRIW SA/ Sofipole SA, Mayo Foundation

Investor Contact Information:

Sara Zelkovic

Communications and IR Director

Investors@celyad.com